Camp4 net loss widens to $33.5 million in Q2 FY26

Reuters2026/08/13 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Camp4 posted a net loss of USD 33.5 million for Q2 2026, widening from USD 12.6 million a year earlier.
RD expense rose to USD 10.8 million from USD 10.3 million; GA edged up to USD 4.3 million from USD 4.2 million.
The loss widened due to a USD 20.9 million non-cash fair-value loss tied to a derivative tranche liability from its September 2025 private placement.
Cash and cash equivalents fell to USD 86.4 million at June 30 from USD 109.5 million at Dec. 31; added USD 50.1 million post-quarter.
Regulatory clearance in Australia and Argentina supports a first-in-human Phase 1/2 CMP-002 trial in SYNGAP1, with launch expected in Q4 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-056758), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Camp4 net loss widens to $33.5 million in Q2 FY26

You may also like

Crypto prices